OTCMKTS:MHTX

Manhattan Scientifics (MHTX) Stock Price, News & Analysis

$0.0014
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$0.0014
$0.0016
50-Day Range
N/A
52-Week Range
$0.0014
$0.0089
Volume
705,250 shs
Average Volume
192,126 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MHTX stock logo

About Manhattan Scientifics Stock (OTCMKTS:MHTX)

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.

MHTX Stock Price History

MHTX Stock News Headlines

Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.
Manhattan DA Says Trump Seeks Special Treatment
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.
Train derails at Lincoln Tunnel in Manhattan
Explosion in Manhattan
Trump Indicted By Manhattan Grand Jury
See More Headlines
Receive MHTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Manhattan Scientifics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/20/2018
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:MHTX
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-1,160,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$50,000.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.27
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Marvin Maslow (Age 86)
    Founder & Chairman of the Board
  • Mr. Emmanuel Tsoupanarias (Age 71)
    President, CEO & Director
    Comp: $186k
  • Mr. Leonard C. Friedman (Age 86)
    Secretary
  • Mr. Robert Romeo Proulx (Age 66)
    President of Imagion
    Comp: $250k

MHTX Stock Analysis - Frequently Asked Questions

How have MHTX shares performed in 2024?

Manhattan Scientifics' stock was trading at $0.0026 at the beginning of the year. Since then, MHTX shares have decreased by 46.2% and is now trading at $0.0014.
View the best growth stocks for 2024 here
.

How were Manhattan Scientifics' earnings last quarter?

Manhattan Scientifics, Inc. (OTCMKTS:MHTX) issued its quarterly earnings data on Monday, August, 20th. The technology company reported $0.00 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Manhattan Scientifics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Scientifics investors own include Sierra Wireless (SW), Advanced Micro Devices (AMD), InterCloud Systems (ICLD), PositiveID (PSID), ARCA biopharma (ABIO), Acorn Energy (ACFN), Aware (AWRE), Alexco Resource (AXU) and Biocept (BIOC).

How do I buy shares of Manhattan Scientifics?

Shares of MHTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MHTX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners